The ACCP Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course will be held Saturday and Sunday, April 27-28, 2019.
Click below for the full meeting schedule.
Pharmacotherapy Preparatory Review and Recertification Course -- Audio Recorded Topics - Men’s and Women’s Health, Pulmonary Disorders, Gout, and Immunizations, Oncology Support Care, and Policy, Practice, and Regulatory Issues
Monday, April 29, 2019
Available for 4.00 hours of CPE credit
Activity Number: 0217-0000-19-086-H01-P
The following topics will be recorded and made available to participants of the course by July 1, 2019. These recorded topics are included in your meeting registration at no additional charge.
Pharmacotherapy Preparatory Review and Recertification Course – Men’s and Women’s Health, Pulmonary Disorders, Gout, and Immunizations, Oncology Support Care, and Policy, Practice, and Regulatory Issues
Activity No. 0217-0000-19-086-H01-P; 4 contact hours; Application-based activity
Men's and Women's Health
|Faculty: Shareen Y. El-Ibiary, Pharm.D., FCCP, BCPS|
Professor, Department of Pharmacy Practice, Midwestern University College of Pharmacy-Glendale, Arizona
1. Recommend appropriate treatment options for patients with menopausal symptoms; osteoporosis; conditions in pregnancy; infertility; and sexual dysfunction.
2. Identify drugs that are considered safe and unsafe during pregnancy and lactation.
3. Modify contraceptive regimens on the basis of estrogen- and progestin-related adverse effects or drug interactions.
4. Devise a pharmacotherapeutic plan for appropriate contraceptive use, contraceptive method mishaps, and use of emergency contraception.
5. Identify common menstrual disorders and sexually transmitted diseases, and recommend appropriate pharmacotherapy.
Pulmonary Disorders, Gout, and Immunizations
|Faculty: Ashley H. Meredith, PharmD, BCACP, BCPS, CDE, FCCP|
Clinical Associate Professor, Purdue University College of Pharmacy; Clinical Pharmacy Specialist, Eskenazi Health, Indianapolis, Indiana
1. Accurately classify patients, assess control, and select and monitor appropriate acute and preventative treatments for pediatric and adult patients with asthma and for adult patients with chronic obstructive pulmonary disease, incorporating patient-specific
2. Appropriately assess, classify, and select pharmacotherapy (acute and long term, including nonpharmacologic therapy), and monitor, reassess, and adjust pharmacotherapy in patients with gout.
3. Determine appropriate immunizations for an adult given his or her age and medical conditions, and correctly apply cautions, contraindications, and drug interactions with immunizations to adult patients.
Oncology Support Care
|Faculty: Christopher T. Elder, Pharm.D., BCOP|
Assistant Professor of Pharmacy Practice, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida
1. Identify, assess, and recommend appropriate pharmacotherapy for managing common complications of cancer chemotherapy, including nausea and vomiting, myelosuppression and the appropriate use of growth factors, infection, anemia and fatigue, cardiotoxicity, and extravasation injury.
2. Assess and recommend appropriate pharmcotherapy for managing cancer-related pain.
3. Assess and recommend appropriate pharmacotherapy for managing oncologic emergencies, including hypercalcemia, tumor lysis syndrome, and spinal cord compression.
Policy, Practice and Regulatory Issues
|Faculty: Kristin Zimmerman, Pharm.D., CGP|
Associate Professor, Department of Pharmacotherapy and Outcomes Science, VCU School of Pharmacy, Richmond, Virginia
1. List the congressional committees and government agencies that regulate health care in the United States.
2. Identify the regulatory and oversight bodies with jurisdiction over health system delivery of care
3. Explain recent federal legislative and regulatory activity that affects the delivery of health care.
4. Describe the regulatory actions that govern the prescription drug approval process and the conduct of human subjects research,
5. Describe national quality initiatives aimed at improving health care delivery and patient health outcomes.
6. Explain medication policy implications at an institutional leve,